8 results found.

Essential Hypertension Complicated by Type 2 Diabetes Mellitus Clinical Trial using Azilsartan; Telmisartan

Takeda - Recruiting 20 years or older.
- A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R.
Azilsartan; Telmisartan

Essential Hypertension, or Hyperlipidemia Clinical Trial using Atorvastatin; Losartan; Placebo; HL-040XC

HanAll BioPharma Co., Ltd. - Recruiting 18 years to 80 years.
- A Phase 3, Randomized, Double- Blind, Multi-center, Double Dummy, Clinical Trial Comparing HL-040XC With Single Component Therapies(Atorvastatin, Losartan) to Assess the Efficacy and Safety of HL-040XC in Patients With Essential Hypertension and Hyperlipidemia.
Atorvastatin; Losartan; Placebo; HL-040XC

Essential Hypertension Clinical Trial using Placebo Single IV (Intravenous) Infusion; Experimental: Single IV Infusion Vasomera (PB1046)

PhaseBio Pharmaceuticals Inc. - Recruiting 18 years to 80 years.
- Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of VasomeraT (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension.
Placebo Single IV (Intravenous) Infusion; Experimental: Single IV Infusion Vasomera (PB1046)

Essential Hypertension Clinical Trial using renal sympathetic modification

The Second Affiliated Hospital of Chongqing Medical University - Recruiting 18 years to 75 years.
- Renal Sympathetic Modification in Patients With Essential Hypertension.
renal sympathetic modification

Essential Hypertension Clinical Trial using Amlodipine, Telmisartan, Amiloride Compound , Simvastatin

Cardiovascular Institute & Fuwai Hospital - Recruiting 50 years to 79 years.
- Phase 4 Study of Effects of ARB Compared With Diuretics in Hypertension Patients With High Cardiovascular Risks.
Amlodipine, Telmisartan, Amiloride Compound , Simvastatin

Essential Hypertension Clinical Trial using Imidapril; Candesartan

University of Pavia - Recruiting 18 years to 65 years.
- Randomized, Controlled, Parallel Arm, PROBE Study to Evaluate Different Effects of Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension.
Imidapril; Candesartan

Essential Hypertension Clinical Trial using OJP-2028

Jeil Pharmaceutical Co., Ltd. - Recruiting 18 years to 75 years.
- A 8-Week, Randomized, Double-Blind, Parallel Designed, Phase II Multi-Center Clinical Trial to Evaluate the Antihypertensive Efficacy and the Safety of OJP-2028 Tablets in Patients With the Uncomplicated Essential Hypertension.
OJP-2028

Essential Hypertension Clinical Trial using telmisartan plus hydrochlorothiazide

Tokyo University - Recruiting 40 years to 80 years.
- ONgoing Evaluation of Depressor Effect And Safety of Combination Therapy With Telmisartan and Low-Dose Hydrochlorothiazide in Patients With Hypertension Uncontrolled on Amlodipine Treatment.
telmisartan plus hydrochlorothiazide